Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Hormone Receptor-positive Advanced Breast Cancer
Interventions: DRUG: chidamide，fulvestrant
Sponsor: The First Affiliated Hospital with Nanjing Medical University